EGFRvIII peptide (PEPvIII)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

EGFRvIII peptide (PEPvIII) 

EGFRvIII peptide (PEPvIII) 是一种肿瘤特异性突变,广泛表达于多形性胶质母细胞瘤 (GBM) 和其他肿瘤中,其表达增强了肿瘤发生率。EGFRvIII peptide (PEPvIII) 是抗肿瘤免疫的一个真正的特异性靶点。

EGFRvIII peptide (PEPvIII)

EGFRvIII peptide (PEPvIII) Chemical Structure

CAS No. : 129112-17-0

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy[1].

分子量

1634.81

Formula

C70H111N19O24S

CAS 号

129112-17-0

Sequence Shortening

LEEKKGNYVVTDHC

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Schmittling RJ, et al. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines. J Immunol Methods. 2008 Nov 30;339(1):74-81.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

发表回复